The aim of the study is to investigate the frequency of thromboembolic complications and the factors influencing them in COVID-19 cases that did not require hospitalization. For this purpose, patients registered at two different family health centers in Istanbul were retrospectively screened, and their status regarding post-COVID-19 thromboembolic events was recorded. The sociodemographic characteristics, medical history, COVID-19 treatments received, comorbidities, and current medications of all patients were examined and compared with the occurrence of complications.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Being over 18 years of age
* Having had a confirmed COVID-19 infection verified by a PCR test
* Being monitored at a family health center without requiring hospitalization during the COVID-19 course
* Having at least 6 months elapsed since the infection
* Availability of the patient's medical records
* Absence of any language barrier or health issue that would prevent communication with the patient
Exclusion Criteria:
* Being under 18 years of age
* Having had less than 6 months since the COVID-19 infection
* Presence of any condition that prevents communication with the patient
* Incomplete or missing medical records of the patient
* History of hospitalization due to COVID-19 infection
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
The frequency of thromboembolic complications in COVID-19 patients not requiring hospitalization.
Timeframe: january-june 2022
2
The relationship between patients' comorbidities and the occurrence of thromboembolic events post-COVID.
Timeframe: january-june 2022
3
The relationship between patients' medications and the occurrence of thromboembolic events post-COVID.
Timeframe: january-june 2022
Trial details
NCT IDNCT06695377
SponsorMarmara University Pendik Training and Research Hospital